Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amuno
2. Indocid
3. Indocin
4. Indomet 140
5. Indometacin
6. Indomethacin
7. Indomethacin Hydrochloride
8. Metindol
9. Osmosin
1. 7681-54-1
2. Osmosin
3. Sodium Indomethacin
4. Indomethacin (sodium)
5. Sodium 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl)acetate
6. Indometacin (sodium)
7. Indocin I.v.
8. Indomethacin Sodium Anhydrous
9. 1h-indole-3-acetic Acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, Sodium Salt
10. 1c9d998830
11. Sodium;2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate
12. Sodium 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate
13. Einecs 231-670-4
14. Sodium 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetate
15. Unii-1c9d998830
16. Indomethacinsodium
17. Indole-3-acetic Acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-, Sodium Salt
18. Schembl3772654
19. Dtxsid20227631
20. Akos016014921
21. Ac-13625
22. Hy-15034
23. Cs-0003710
24. Q27252232
25. Sodium,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate
26. 1h-indole-3-acetic Acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, Sodium Salt (1:1)
Molecular Weight | 379.8 g/mol |
---|---|
Molecular Formula | C19H15ClNNaO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 379.0587299 g/mol |
Monoisotopic Mass | 379.0587299 g/mol |
Topological Polar Surface Area | 71.4 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 512 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Indomethacin sodium |
Active Ingredient | Indomethacin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Indomethacin sodium |
Active Ingredient | Indomethacin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cardiovascular Agents
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
Gout Suppressants
Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
Related Excipient Companies
ABOUT THIS PAGE
A Indomethacin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indomethacin Sodium, including repackagers and relabelers. The FDA regulates Indomethacin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indomethacin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indomethacin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indomethacin Sodium supplier is an individual or a company that provides Indomethacin Sodium active pharmaceutical ingredient (API) or Indomethacin Sodium finished formulations upon request. The Indomethacin Sodium suppliers may include Indomethacin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Indomethacin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indomethacin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Indomethacin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Indomethacin Sodium DMFs exist exist since differing nations have different regulations, such as Indomethacin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indomethacin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Indomethacin Sodium USDMF includes data on Indomethacin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indomethacin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indomethacin Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Indomethacin Sodium Drug Master File in Japan (Indomethacin Sodium JDMF) empowers Indomethacin Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Indomethacin Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Indomethacin Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Indomethacin Sodium suppliers with JDMF on PharmaCompass.
A Indomethacin Sodium written confirmation (Indomethacin Sodium WC) is an official document issued by a regulatory agency to a Indomethacin Sodium manufacturer, verifying that the manufacturing facility of a Indomethacin Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Indomethacin Sodium APIs or Indomethacin Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Indomethacin Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Indomethacin Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Indomethacin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Indomethacin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Indomethacin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Indomethacin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Indomethacin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Indomethacin Sodium suppliers with NDC on PharmaCompass.
Indomethacin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indomethacin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indomethacin Sodium GMP manufacturer or Indomethacin Sodium GMP API supplier for your needs.
A Indomethacin Sodium CoA (Certificate of Analysis) is a formal document that attests to Indomethacin Sodium's compliance with Indomethacin Sodium specifications and serves as a tool for batch-level quality control.
Indomethacin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Indomethacin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indomethacin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Indomethacin Sodium EP), Indomethacin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indomethacin Sodium USP).
LOOKING FOR A SUPPLIER?